 | Monter d'un niveau |
Astolfi, M., St-Georges-Robillard, A., Leblond, F., Mes-Masson, A.-M., & Gervais, T. (2016). Microfluidics and spectroscopic imaging for personalized medicine in ovarian cancer. SPIE Newsroom. Lien externe
Lateef, M. A., Péant, B., Rousset, N., Simeone, K., Kendall-Dupont, J., Mari Orimoto, A., Mes-Masson, A.-M., Gervais, T., & Saad, F. (juin 2016). Rapid prediction of personalized response to chemotherapy using sub-millimeter ex-vivo biopsy samples on chip [Affiche]. Congrès annuel de l'Association des urologues du Canada (CUA 2016), Vancouver, B.-C.. Lien externe
Madore, W. J., De Montigny, E., Deschênes, A., Benboujja, F., Leduc, M., Mes-Masson, A.-M., Provencher, D., Rahimi, K., Boudoux, C., & Godbout, N. (février 2016). Morphologic 3D scanning of fallopian tubes to assist ovarian cancer diagnosis [Communication écrite]. Photonic Therapeutics and Diagnostics XII, San Francisco, California. Lien externe
Patra, B., Carmona, E., Lateef, M. A., Kendall-Dupont, J., Péant, B., Provencher, D., Mes-Masson, A.-M., & Gervais, T. (octobre 2016). Are 3D spheroids always more resistant to chemotherapy than 2D cultures? A chip-based survey using ovarian cancer cell lines [Communication écrite]. 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2016), Dublin, Ireland. Lien externe
Lateef, M. A., Péant, B., Carmona, E.́., Rousset, N., Simeone, K., Kendall-Dupont, J., Orimoto, A. M., Mes-Masson, A.-M., Gervais, T., & Saad, F. (juin 2016). The use of a microfluidic chip platform for the ex vivo rapid measurement of chemotherapeutic responses in 3D sub millimeter biopsy samples . Dans American Society of Clinical Oncology (ASCO) Annual Meeting I, Chicago, Illinois. Publié dans Journal of Clinical Oncology, 34(15_suppl). Lien externe
